ArticleTranslational psychiatry2026
The genetic relationship between ADHD and shortened telomeres points to neurodevelopmental mechanisms.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) is often accompanied by other psychiatric and somatic conditions. Telomere shortening as an accelerated biological aging marker may underlie this aggregate burden. Telomere length (TL) has previously been associated with childhood inattention and hyperactivity, as well as other neuropsychiatric conditions. We hypothesize that TL and ADHD may share overlapping genetic influences, suggesting that some of the same genes could affect both cellular aging and ADHD traits. We investigated the pleiotropic and causal associations between these traits. Using the latest and largest publicly available genome-wide association study (GWAS) summary data for ADHD (38,691 cases and 186,843 controls) and TL (472,174 subjects), we tested causality, global and local genetic correlations, and joint genomic effects. Polygenic scores (PGS) were evaluated in an independent clinical sample of 665 ADHD cases and 995 controls, and TL was quantified via qPCR in a subsample of 370 subjects. The pleiotropy analysis showed global and local (a chromosome 17 locus) negative correlations. Shared genomic analysis showed loci enriched across several chromosomes, notably including the same chromosome 17 locus. This locus contains a diverse set of genes involved in many biological pathways impacting core cellular functions, tissue development, cell cycle, and apoptosis. Mendelian randomization indicated a unidirectional causal effect of ADHD on shorter TL across four methods. In our independent clinical sample, TL was shorter in individuals with ADHD. Lastly, higher PGS for longer TL was associated with reduced ADHD symptomatology. Our findings suggest that ADHD may contribute to TL, and genetic predisposition to shorter TL is associated with greater ADHD severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.